{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:46:21Z","timestamp":1791384381744,"version":"4.3.3"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00210-025-04344-z","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:28:33Z","timestamp":1750051713000},"page":"17609-17632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting inflammation-driven tumor progression with Zafirlukast via modulation of Jagged-1\/Notch-1\/Hes-1, Wnt-4\/\u03b2-catenin, and VEGF signaling pathways in mice"],"prefix":"10.1007","volume":"398","author":[{"given":"Asmaa","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina F.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed A.","family":"Raslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omneya","family":"Galal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza M.","family":"Elhusseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Mohammed Refat M.","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"Farghly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad Yahia","family":"Abdoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiaa A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa M.","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Dessouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"4344_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120497","volume":"299","author":"MA Abd El-Salam","year":"2022","unstructured":"Abd El-Salam MA, El-Tanbouly GS, Bastos JK, Metwaly HA (2022) Novel antitumor activity of the combined treatment of galloylquinic acid compounds with doxorubicin in solid Ehrlich carcinoma model via the notch signaling pathway modulation. Life Sci 299:120497","journal-title":"Life Sci"},{"key":"4344_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117038","volume":"490","author":"WH Abdulaal","year":"2024","unstructured":"Abdulaal WH, Omar UM, Zeyadi M, El-Agamy DS, Alhakamy NA, Ibrahim SR, Almalki NA, Asfour HZ, Al-Rabia MW, Mohamed GA, Pharmacology A (2024) Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-\u043aB\/TNF-\u03b1, and Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling pathways. Toxicol Appl Pharmacol 490:117038","journal-title":"Toxicol Appl Pharmacol"},{"key":"4344_CR3","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.3390\/molecules26227021","volume":"26","author":"AE Albalawi","year":"2021","unstructured":"Albalawi AE, Althobaiti NA, Alrdahe SS, Alhasani RH, Alaryani FS, BinMowyna MN (2021) Anti-tumor effects of queen bee acid (10-hydroxy-2-decenoic acid) alone and in combination with cyclophosphamide and its cellular mechanisms against Ehrlich solid tumor in mice. Molecules 26:7021","journal-title":"Molecules"},{"key":"4344_CR4","first-page":"44987","volume":"15","author":"BM Alfair","year":"2023","unstructured":"Alfair BM, Jabarti AA, Albalawi SS, Khodir AE, Al-Gayyar MM (2023) Arctiin inhibits inflammation, fibrosis, and tumor cell migration in rats with Ehrlich solid carcinoma. Cureus 15:44987","journal-title":"Cureus"},{"key":"4344_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/acs.jmedchem.3c01708","volume":"67","author":"AA Al-Karmalawy","year":"2023","unstructured":"Al-Karmalawy AA, Mousa MH, Sharaky M, Mourad MA, El-Dessouki AM, Hamouda AO, Alnajjar R, Ayed AA, Shaldam MA, Tawfik HO (2023) Lead optimization of BIBR1591 to improve its telomerase inhibitory activity: design and synthesis of novel four chemical series with in silico, in vitro, and in vivo preclinical assessments. J Med Chem 67:492\u2013512","journal-title":"J Med Chem"},{"key":"4344_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122688","volume":"348","author":"SA Antar","year":"2024","unstructured":"Antar SA, Abdo W, Helal AI, Abduh MS, Hakami ZH, Germoush MO, Alsulimani A, Al-Noshokaty TM, El-Dessouki AM, ElMahdy MK (2024) Coenzyme Q10 mitigates cadmium cardiotoxicity by downregulating NF-\u03baB\/NLRP3 inflammasome axis and attenuating oxidative stress in mice. Life Sci 348:122688","journal-title":"Life Sci"},{"key":"4344_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10753-024-02046-x","volume":"48","author":"AM Badr","year":"2024","unstructured":"Badr AM, Alotaibi HN, El-Orabi N (2024) Dibenzazepine, a \u03b3-secretase enzyme inhibitor, protects against doxorubicin-induced cardiotoxicity by suppressing NF-\u03baB, iNOS, and Hes1\/Hey1 expression. Inflammation 48:557\u2013574","journal-title":"Inflammation"},{"key":"4344_CR8","first-page":"132873","volume":"2015","author":"W Barakat","year":"2015","unstructured":"Barakat W, Elshazly SM, Mahmoud AA (2015) Spirulina platensis lacks antitumor effect against solid Ehrlich carcinoma in female mice. Adv Pharmacol Pharm Sci 2015:132873","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"4344_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/antiox12040901","volume":"12","author":"A Bardel\u010d\u00edkov\u00e1","year":"2023","unstructured":"Bardel\u010d\u00edkov\u00e1 A, \u0160oltys J, Moj\u017ei\u0161 J (2023) Oxidative stress, inflammation and colorectal cancer: an overview. Antioxidants 12:901","journal-title":"Antioxidants"},{"key":"4344_CR10","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 74:229\u2013263","journal-title":"CA: A Cancer J Clin"},{"key":"4344_CR11","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.3390\/cimb44100305","volume":"44","author":"M Cao","year":"2022","unstructured":"Cao M, Wang Y, Lu G, Qi H, Li P, Dai X, Lu J (2022) Classical angiogenic signaling pathways and novel anti-angiogenic strategies for colorectal cancer. Curr Issues Mol Biol 44:4447\u20134471","journal-title":"Curr Issues Mol Biol"},{"key":"4344_CR12","first-page":"128","volume":"4","author":"W Cao","year":"2024","unstructured":"Cao W, Qin K, Li F, Chen W (2024) Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J Nat Cancer Cent 4:128\u2013134","journal-title":"J Nat Cancer Cent"},{"key":"4344_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0930-x","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wang D, Peng H, Chen X, Han X, Yu J, Wang W, Liang L, Liu Z, Zheng Y (2019) Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLC\u03b5-NF-\u03baB signaling pathway and VEGF-C\/Bcl-2 expression. Mol Cancer 18:1\u201319","journal-title":"Mol Cancer"},{"key":"4344_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/gutjnl-2022-327076","volume":"72","author":"L Chen","year":"2023","unstructured":"Chen L, Lu H, Peng D, Cao LL, Ballout F, Srirmajayam K, Chen Z, Bhat A, Wang TC, Capobianco A (2023) Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-\u03baB activation in oesophageal adenocarcinoma. Gut 72:421\u2013432","journal-title":"Gut"},{"key":"4344_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/carcin\/bgae049","volume":"45","author":"G Chiappara","year":"2024","unstructured":"Chiappara G, Di Vincenzo S, Cascio C, Pace E (2024) Stem cells, Notch-1 signaling, and oxidative stress: a hellish trio in cancer development and progression within the airways. Is there a role for natural compounds? Carcinogenesis 45:621\u2013629","journal-title":"Carcinogenesis"},{"key":"4344_CR16","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260807","volume":"136","author":"RA Cooney","year":"2023","unstructured":"Cooney RA, Saal ML, Geraci KP, Maynard C, Cleaver O, Hoang ON, Moore TT, Hwang RF, Axelrod JD, Vladar EK (2023) A WNT4-and DKK3-driven canonical to noncanonical WNT signaling switch controls multiciliogenesis. J Cell Sci 136:260807","journal-title":"J Cell Sci"},{"key":"4344_CR17","doi-asserted-by":"publisher","first-page":"1057181","DOI":"10.3389\/fimmu.2022.1057181","volume":"13","author":"G Cui","year":"2022","unstructured":"Cui G, Wang Z, Liu H, Pang Z (2022) Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications. Front Immunol 13:1057181","journal-title":"Front Immunol"},{"key":"4344_CR18","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1007\/s12010-022-04266-z","volume":"195","author":"LCP Dharshini","year":"2023","unstructured":"Dharshini LCP, Rasmi RR, Kathirvelan C, Kumar KM, Saradhadevi K, Sakthivel KM (2023) Regulatory components of oxidative stress and inflammation and their complex interplay in carcinogenesis. Appl Biochem Biotechnol 195:2893\u20132916","journal-title":"Appl Biochem Biotechnol"},{"key":"4344_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0016-5085(22)60968-5","volume":"162","author":"C Di Giorgio","year":"2022","unstructured":"Di Giorgio C, Biagioli M, Marchian\u00f2 S, Bordoni M, Bellini R, Roselli R, Zampella A, Fiorucci S (2022) Discovery of a novel cysteinyl-leukotriene-receptor 1 antagonist and bile acid receptor gpbar1 agonist that reduces inflammation in a mouse model of colitis. Gastroenterology 162:407","journal-title":"Gastroenterology"},{"key":"4344_CR20","doi-asserted-by":"publisher","first-page":"81803","DOI":"10.18632\/oncotarget.19413","volume":"8","author":"G Di Sante","year":"2017","unstructured":"Di Sante G, Di Rocco A, Pupo C, Casimiro MC, Pestell RG (2017) Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer. Oncotarget 8:81803","journal-title":"Oncotarget"},{"key":"4344_CR21","doi-asserted-by":"publisher","first-page":"103943","DOI":"10.1016\/j.etap.2022.103943","volume":"95","author":"NH Eisa","year":"2022","unstructured":"Eisa NH, Said E, Khodir AE, Sabry D, Ebrahim HA, Elsherbini DMA, Altemani R, Alnasser DM, Elsherbiny NM, El-Sherbiny M (2022) Effect of Diacerein on HOTAIR\/IL-6\/STAT3, Wnt\/\u03b2-Catenin and TLR-4\/NF-\u03baB\/TNF-\u03b1 axes in colon carcinogenesis. Environ Toxicol Pharmacol 95:103943","journal-title":"Environ Toxicol Pharmacol"},{"key":"4344_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2018.04.002","volume":"202","author":"AM El-Dessouki","year":"2018","unstructured":"El-Dessouki AM, El Fattah MA, Awad AS, Zaki HF (2018) Zafirlukast and vincamine ameliorate tamoxifen-induced oxidative stress and inflammation: Role of the JNK\/ERK pathway. Life Sci 202:78\u201388","journal-title":"Life Sci"},{"key":"4344_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112511","volume":"137","author":"AM El-Dessouki","year":"2024","unstructured":"El-Dessouki AM, Alzokaky AA, Raslan NA, Ibrahim S, Salama LA, Yousef EH (2024a) Piracetam mitigates nephrotoxicity induced by cisplatin via the AMPK-mediated PI3K\/Akt and MAPK\/JNK\/ERK signaling pathways. Int Immunopharmacol 137:112511","journal-title":"Int Immunopharmacol"},{"key":"4344_CR24","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1007\/s00210-024-03567-w","volume":"398","author":"AM El-Dessouki","year":"2024","unstructured":"El-Dessouki AM, Alzokaky AA, Raslan NA, Ibrahim S, Selim HMRM, Al-Karmalawy AA (2024b) Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NFkB\/IL-1\u03b2\/MCP-1 and TLR4\/NLRP3 signaling pathways. Naunyn Schmiedeberg's Arch Pharmacol 398:5129\u20135145","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4344_CR25","first-page":"1","volume":"25","author":"AM El-Dessouki","year":"2025","unstructured":"El-Dessouki AM, Kaml ME, El-Yamany MF (2025a) Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK\/JNK\/ERK, JAK1\/STAT3, and PI3K\/Akt signaling pathways. Naunyn Schmiedeberg's Arch Pharmacol 25:1\u201319","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4344_CR26","first-page":"1","volume":"25","author":"AM El-Dessouki","year":"2025","unstructured":"El-Dessouki AM, Yousef EH, Raslan NA, Alwakeel AI, Ibrahim S, Alzokaky AA (2025b) Febuxostat protects from doxorubicin induced hepatotoxicity in rats via regulation of NF-\u03baB p65\/NLRP3 inflammasome and SIRT-1\/AMPK pathways. Naunyn Schmiedeberg's Arch Pharmacol 25:1\u201313","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4344_CR27","first-page":"100620","volume-title":"Cancer Treat Res Commun","author":"TC Elebiyo","year":"2022","unstructured":"Elebiyo TC, Rotimi D, Evbuomwan IO, Maimako RF, Iyobhebhe M, Ojo OA, Oluba OM, Adeyemi OS (2022) Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. Cancer Treat Res Commun 32:100620"},{"key":"4344_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22228","volume":"85","author":"DS El-Gamil","year":"2024","unstructured":"El-Gamil DS, Zaky MY, Maximous PM, Sharaky M, El-Dessouki AM, Riad NM, Shaaban S, Abdel-Halim M, Al-Karmalawy AA (2024) Exploring chromone-2-carboxamide derivatives for triple-negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: design, synthesis, and preclinical insights. Drug Dev Res 85:e22228","journal-title":"Drug Dev Res"},{"key":"4344_CR29","first-page":"527","volume":"17","author":"TA El-Masry","year":"2024","unstructured":"El-Masry TA, El-Nagar MM, El Mahdy NA, Alherz FA, Taher R, Osman EY (2024) Potential antitumor activity of combined lycopene and sorafenib against solid ehrlich carcinoma via targeting autophagy and apoptosis and suppressing proliferation. Pharm 17:527","journal-title":"Pharm"},{"key":"4344_CR30","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/antiox10121906","volume":"10","author":"MR Farag","year":"2021","unstructured":"Farag MR, Moselhy AA, El-Mleeh A, Aljuaydi SH, Ismail TA, Di Cerbo A, Crescenzo G, Abou-Zeid SM (2021) Quercetin alleviates the immunotoxic impact mediated by oxidative stress and inflammation induced by doxorubicin exposure in rats. Antioxidants 10:1906","journal-title":"Antioxidants"},{"key":"4344_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2021.04.002","volume":"124","author":"AA Farooqi","year":"2022","unstructured":"Farooqi AA, Naureen H, Attar R (2022) Regulation of cell signaling pathways by circular RNAs and microRNAs in different cancers: spotlight on Wnt\/\u03b2-catenin, JAK\/STAT, TGF\/SMAD, SHH\/GLI, NOTCH and hippo pathways. Semin Cell Dev Biol 124:72\u201381","journal-title":"Semin Cell Dev Biol"},{"key":"4344_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fphar.2019.00263","volume":"10","author":"T G\u00f6bel","year":"2019","unstructured":"G\u00f6bel T, Diehl O, Heering J, Merk D, Angioni C, Wittmann SK, El B, Kottke R, Weizel L, Schader T (2019) Zafirlukast is a dual modulator of human soluble epoxide hydrolase and peroxisome proliferator-activated receptor \u03b3. Front Pharmacol 10:263","journal-title":"Front Pharmacol"},{"key":"4344_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2017.08.013","volume":"112","author":"B Griess","year":"2017","unstructured":"Griess B, Tom E, Domann F, Teoh-Fitzgerald M (2017) Extracellular superoxide dismutase and its role in cancer. Free Radical Biol Med 112:464\u2013479","journal-title":"Free Radical Biol Med"},{"key":"4344_CR34","doi-asserted-by":"publisher","first-page":"5801209","DOI":"10.1155\/2018\/5801209","volume":"2018","author":"H Gu","year":"2018","unstructured":"Gu H, Huang T, Shen Y, Liu Y, Zhou F, Jin Y, Sattar H, Wei Y (2018) Reactive oxygen species-mediated tumor microenvironment transformation: the mechanism of radioresistant gastric cancer. Oxid Med Cell Longev 2018:5801209","journal-title":"Oxid Med Cell Longev"},{"key":"4344_CR35","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3390\/cancers14092066","volume":"14","author":"K Hamaguchi","year":"2022","unstructured":"Hamaguchi K, Miyanishi K, Osuga T, Tanaka S, Ito R, Sakamoto H, Kubo T, Ohnuma H, Murase K, Takada K (2022) Association between hepatic oxidative stress related factors and activation of Wnt\/\u03b2-catenin signaling in NAFLD induced hepatocellular carcinoma. Cancers 14:2066","journal-title":"Cancers"},{"key":"4344_CR36","first-page":"1","volume":"17","author":"RA Hassan","year":"2023","unstructured":"Hassan RA, Mahmood SS, Askar BA (2023) Roles of IL-6, TNF-\u03b1 and \u03b2-catenin in patients with colorectal cancer. Oncol Radiother 17:1\u20138","journal-title":"Oncol Radiother"},{"key":"4344_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116527","volume":"274","author":"SM Hefny","year":"2024","unstructured":"Hefny SM, El-Moselhy TF, El-Din N, Ammara A, Angeli A, Ferraroni M, El-Dessouki AM, Shaldam MA, Yahya G, Al-Karmalawy A (2024a) A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments. Eur J Med Chem 274:116527","journal-title":"Eur J Med Chem"},{"key":"4344_CR38","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","volume":"67","author":"SM Hefny","year":"2024","unstructured":"Hefny SM, El-Moselhy TF, El-Din N, Giovannuzzi S, Bin Traiki T, Vaali-Mohammed M-A, El-Dessouki AM, Yamaguchi K, Sugiura M, Shaldam MA (2024b) Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, in vitro, in vivo, and in silico investigations of Coumarin-based Thiazoles. J Med Chem 67:7406\u20137430","journal-title":"J Med Chem"},{"key":"4344_CR39","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3390\/ijms22115421","volume":"22","author":"S Hibino","year":"2021","unstructured":"Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M, Taniguchi K (2021) Inflammation-induced tumorigenesis and metastasis. Int J Mol Sci 22:5421","journal-title":"Int J Mol Sci"},{"key":"4344_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fonc.2018.00575","volume":"8","author":"F Hossain","year":"2018","unstructured":"Hossain F, Sorrentino C, Ucar DA, Peng Y, Matossian M, Wyczechowska D, Crabtree J, Zabaleta J, Morello S, Del Valle L (2018) Notch signaling regulates mitochondrial metabolism and NF-\u03baB activity in triple-negative breast cancer cells via IKK\u03b1-dependent non-canonical pathways. Front Oncol 8:575","journal-title":"Front Oncol"},{"key":"4344_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12935-023-02973-z","volume":"23","author":"C Hu","year":"2023","unstructured":"Hu C, Ye M, Bai J, Liu P, Lu F, Chen J, Yu P, Chen T, Shi X, Tang QJCCI (2023) Methylmalonic acid promotes colorectal cancer progression via activation of Wnt\/\u03b2-catenin pathway mediated epithelial\u2013mesenchymal transition. Cancer Cell Int 23:131","journal-title":"Cancer Cell Int"},{"key":"4344_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0621-z","volume":"16","author":"SA Ibrahim","year":"2017","unstructured":"Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, G\u00f6tte M (2017) Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6\/STAT3, Notch and EGFR signaling pathways. Mol Cancer 16:1\u201319","journal-title":"Mol Cancer"},{"key":"4344_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajo.2024.01.016","volume":"262","author":"A Jhaveri","year":"2024","unstructured":"Jhaveri A, Balas M, Khalid F, Mihalache A, Popovic MM, Kertes PJ, Muni RH (2024) Systemic arterial and venous thrombotic events associated with anti-vascular endothelial growth factor injections: a meta-analysis. Am J Ophthalmol 262:86\u201396","journal-title":"Am J Ophthalmol"},{"key":"4344_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.5056","volume":"49","author":"Y Ji","year":"2022","unstructured":"Ji Y, Lv J, Sun D, Huang Y (2022) Therapeutic strategies targeting Wnt\/\u03b2-catenin signaling for colorectal cancer. Int J Mol Med 49:1\u201317","journal-title":"Int J Mol Med"},{"key":"4344_CR45","first-page":"291","volume":"14","author":"N Jiang","year":"2022","unstructured":"Jiang N, Hu Y, Wang M, Zhao Z, Li M (2022) The notch signaling pathway contributes to angiogenesis and tumor immunity in breast cancer. Breast Cancer : Targets Ther 14:291\u2013309","journal-title":"Breast Cancer : Targets Ther"},{"key":"4344_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s12640-023-00652-5","volume":"41","author":"K Kami\u0144ska","year":"2023","unstructured":"Kami\u0144ska K, Cudnoch-J\u0119drzejewska A (2023) A review on the neurotoxic effects of doxorubicin. Neurotox Res 41:383\u2013397","journal-title":"Neurotox Res"},{"key":"4344_CR47","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/cells10113194","volume":"10","author":"K Kashfi","year":"2021","unstructured":"Kashfi K, Kannikal J, Nath N (2021) Macrophage reprogramming and cancer therapeutics: role of iNOS-derived NO. Cells 10:3194","journal-title":"Cells"},{"key":"4344_CR48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/cancers11030316","volume":"11","author":"Y Katayama","year":"2019","unstructured":"Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, Takayama K (2019) Tumor neovascularization and developments in therapeutics. Cancers 11:316","journal-title":"Cancers"},{"key":"4344_CR49","doi-asserted-by":"publisher","first-page":"a041172","DOI":"10.1101\/cshperspect.a041172","volume":"13","author":"AG Kelly","year":"2023","unstructured":"Kelly AG, Panigrahy D (2023) Targeting angiogenesis via resolution of inflammation. Cold Spring Harb Perspect Med 13:a041172","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4344_CR50","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s43440-021-00258-8","volume":"73","author":"H Khan","year":"2021","unstructured":"Khan H, Gupta A, Singh TG, Kaur A (2021) Mechanistic insight on the role of leukotriene receptors in ischemic\u2013reperfusion injury. Pharmacol Rep 73:1240\u20131254","journal-title":"Pharmacol Rep"},{"key":"4344_CR51","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","volume":"31","author":"A Khan","year":"2024","unstructured":"Khan A, Zhang Y, Ma N, Shi J, Hou Y (2024) NF-\u03baB role on tumor proliferation, migration, invasion and immune escape. Cancer Gene Ther 31:1599\u20131610","journal-title":"Cancer Gene Ther"},{"key":"4344_CR52","first-page":"1327","volume-title":"Handbook of oxidative stress in cancer: mechanistic aspects","author":"V Kumar","year":"2021","unstructured":"Kumar V, Vashishta M, Dwarakanath BS (2021) Oxidative stress and notch signaling: implications in Cancer. In: Handbook of oxidative stress in cancer: mechanistic aspects, vol 18, pp 1327\u20131343"},{"key":"4344_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"C-L Kuo","year":"2022","unstructured":"Kuo C-L, Ponneri Babuharisankar A, Lin Y-C, Lien H-W, Lo YK, Chou H-Y, Tangeda V, Cheng L-C, Cheng AN, Lee AY-L (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci 29:74","journal-title":"J Biomed Sci"},{"key":"4344_CR54","first-page":"95","volume":"4","author":"H-H Lee","year":"2018","unstructured":"Lee H-H, Chiang W-H, Shian-Huey C, Liu Y-C, Hwang J, Ng S-Y (2018) Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle. Gene Expr 4:95","journal-title":"Gene Expr"},{"key":"4344_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev-pathmechdis-111523-023509","volume":"20","author":"M Lee","year":"2024","unstructured":"Lee M, Boyce JA, Barrett NA (2024) Cysteinyl leukotrienes in allergic inflammation. Annu Rev Pathol : Mech Dis Annu Rev Pathol 20:115\u2013141","journal-title":"Annu Rev Pathol : Mech Dis Annu Rev Pathol"},{"key":"4344_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, Kaur B, Han H, Yu J (2023) The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol 16:45","journal-title":"J Hematol Oncol"},{"key":"4344_CR57","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/antiox11061195","volume":"11","author":"K Lin","year":"2022","unstructured":"Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M, Bonavida B (2022) The breast cancer protooncogenes HER2, BRCA1 and BRCA2 and their regulation by the iNOS\/NOS2 axis. Antioxidants 11:1195","journal-title":"Antioxidants"},{"key":"4344_CR58","doi-asserted-by":"publisher","first-page":"115299","DOI":"10.1016\/j.bcp.2022.115299","volume":"206","author":"X Ma","year":"2022","unstructured":"Ma X, Hu X, Zhu Y, Jin H, Hu G, Ding L, Ning S (2022) Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt\/\u03b2-catenin signaling. Biochem Pharmacol 206:115299","journal-title":"Biochem Pharmacol"},{"key":"4344_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110498","volume":"122","author":"HM Mahmoud","year":"2023","unstructured":"Mahmoud HM, Abouzed DEE, Abo-Youssef AM, Hemeida RA (2023) Zafirlukast protects against hepatic ischemia\u2013reperfusion injury in rats via modulating Bcl-2\/Bax and NF-\u03baB\/SMAD-4 pathways. Int Immunopharmacol 122:110498","journal-title":"Int Immunopharmacol"},{"key":"4344_CR60","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.3390\/cancers13133209","volume":"13","author":"J Martinez-Useros","year":"2021","unstructured":"Martinez-Useros J, Martin-Galan M, Florez-Cespedes M, Garcia-Foncillas J (2021) Epigenetics of most aggressive solid tumors: pathways, targets and treatments. Cancers 13:3209","journal-title":"Cancers"},{"key":"4344_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1872213X14666200130095040","volume":"14","author":"D Meshram","year":"2020","unstructured":"Meshram D, Bhardwaj K, Rathod C, Mahady GB, Soni KK (2020) The role of leukotrienes inhibitors in the management of chronic inflammatory diseases. Recent Pat Inflamm Allergy Drug Discov 14:15\u201331","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"4344_CR62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00210-020-01988-x","volume":"394","author":"F Nasser","year":"2021","unstructured":"Nasser F, Moussa N, Helmy MW, Haroun M (2021) Dual targeting of Notch and Wnt\/\u03b2-catenin pathways: Potential approach in triple-negative breast cancer treatment. Naunyn Schmiedebergs Arch Pharmacol 394:481\u2013490","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4344_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.22159\/ijpps.2018v10i2.21633","volume":"10","author":"BK Nayak","year":"2018","unstructured":"Nayak BK, Kumar A, Kothiyal PJIJPPS (2018) Pharmacological evaluation of zafirlukast in experimentally induced global cerebral ischemia\/reperfusion injury in mice. Int J Pharm Pharm Sci 10:30\u201336","journal-title":"Int J Pharm Pharm Sci"},{"key":"4344_CR64","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.3390\/cancers13236062","volume":"13","author":"M Neganova","year":"2021","unstructured":"Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R (2021) Therapeutic influence on important targets associated with chronic inflammation and oxidative stress in cancer treatment. Cancers 13:6062","journal-title":"Cancers"},{"key":"4344_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115380","volume":"411","author":"SE Owumi","year":"2021","unstructured":"Owumi SE, Nwozo SO, Arunsi UO, Oyelere AK, Odunola OA (2021) Co-administration of Luteolin mitigated toxicity in rats' lungs associated with doxorubicin treatment. Toxicol Appl Pharmacol 411:115380","journal-title":"Toxicol Appl Pharmacol"},{"key":"4344_CR66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40364-021-00308-6","volume":"9","author":"S Pabla","year":"2021","unstructured":"Pabla S, Seager R, Van Roey E, Gao S, Hoefer C, Nesline MK, DePietro P, Burgher B, Andreas J, Giamo V (2021) Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response. Biomarker Res 9:56","journal-title":"Biomarker Res"},{"key":"4344_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0471-6","volume":"10","author":"SG Pai","year":"2017","unstructured":"Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles F (2017) Wnt\/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 10:1\u201312","journal-title":"J Hematol Oncol"},{"key":"4344_CR68","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s11255-023-03547-8","volume":"55","author":"X Pang","year":"2023","unstructured":"Pang X, Hou X, Hu C, Lu S, Gan H, Yang H, Xiang S, Zhou J, Gao H, Chen S (2023) Tenascin-C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the \u03b2-catenin pathway. Int Urol Nephrol 55:2507\u20132516","journal-title":"Int Urol Nephrol"},{"key":"4344_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel SA, Nilsson MB, Le X, Cascone T, Jain RK, Heymach JVJCCR (2023) Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy. Clin Cancer Res 29:30\u201339","journal-title":"Clin Cancer Res"},{"key":"4344_CR70","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.rpor.2020.04.004","volume":"25","author":"I Piotrowski","year":"2020","unstructured":"Piotrowski I, Kulcenty K, Suchorska W (2020) Interplay between inflammation and cancer. Rep Pract Oncol Radiother 25:422\u2013427","journal-title":"Rep Pract Oncol Radiother"},{"key":"4344_CR71","first-page":"806","volume":"57","author":"LM Radulescu","year":"2021","unstructured":"Radulescu LM, Radulescu D, Ciuleanu T-E, Crisan D, Buzdugan E, Romitan D-M, Buzoianu ADJM (2021) Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours 57:806","journal-title":"Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours"},{"key":"4344_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/fcp.12941","volume":"38","author":"Q Rao","year":"2024","unstructured":"Rao Q, Yu H, Li R, He B, Wang Y, Guo X, Zhao G, Wu F (2024) Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2\/-9. Fundam Clin Pharmacol 38:113\u2013125","journal-title":"Fundam Clin Pharmacol"},{"key":"4344_CR73","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/cells11223698","volume":"11","author":"M Ra\u0161kov\u00e1","year":"2022","unstructured":"Ra\u0161kov\u00e1 M, Lacina L, Kej\u00edk Z, Venhauerov\u00e1 A, Skali\u010dkov\u00e1 M, Kol\u00e1\u0159 M, Jakubek M, Rosel D, Smetana K Jr, Br\u00e1bek J (2022) The role of IL-6 in cancer cell invasiveness and metastasis\u2014overview and therapeutic opportunities. Cells 11:3698","journal-title":"Cells"},{"key":"4344_CR74","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaci.2024.05.026","volume":"154","author":"DG Rayner","year":"2024","unstructured":"Rayner DG, Liu M, Chu AW, Chu X, Guyatt GH, Oykhman P, Cao DJ, Moellman J, Ben-Shoshan M, Baker DR (2024) Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol 154:996\u20131007","journal-title":"J Allergy Clin Immunol"},{"key":"4344_CR75","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1111\/febs.16815","volume":"291","author":"N Sachan","year":"2024","unstructured":"Sachan N, Sharma V, Mutsuddi M, Mukherjee A (2024) Notch signalling: multifaceted role in development and disease. FEBS J 291:3030\u20133059","journal-title":"FEBS J"},{"key":"4344_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150348","volume":"729","author":"C Samant","year":"2024","unstructured":"Samant C, Kale R, Pai KSR, Nandakumar K, Bhonde M (2024) Role of Wnt\/\u03b2-catenin pathway in cancer drug resistance: insights into molecular aspects of major solid tumors. Biochem Biophys Res Commun 729:150348","journal-title":"Biochem Biophys Res Commun"},{"key":"4344_CR77","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/cancers14081912","volume":"14","author":"F Selvaggi","year":"2022","unstructured":"Selvaggi F, Catalano T, Cotellese R, Aceto GM (2022) Targeting Wnt\/\u03b2-catenin pathways in primary liver tumours: from microenvironment signaling to therapeutic agents. Cancers 14:1912","journal-title":"Cancers"},{"key":"4344_CR78","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/tox.22578","volume":"33","author":"S Shahin","year":"2018","unstructured":"Shahin S, Singh SP, Chaturvedi CM (2018) 2.45 GHz microwave radiation induced oxidative and nitrosative stress mediated testicular apoptosis: Involvement of a p53 dependent bax-caspase-3 mediated pathway. Environ Toxicol 33:931\u2013945","journal-title":"Environ Toxicol"},{"key":"4344_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107843","volume":"153","author":"MA Shaldam","year":"2024","unstructured":"Shaldam MA, Mousa MH, Tawfik HO, El-Dessouki AM, Sharaky M, Saleh MM, Alzahrani AYA, Moussa SB, Al-Karmalawy AA (2024) Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl) thio) acetamide candidates as telomerase\/JAK1\/STAT3\/TLR4 inhibitors: in vitro and in vivo investigations. Bioorg Chem 153:107843","journal-title":"Bioorg Chem"},{"key":"4344_CR80","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12935-022-02538-6","volume":"22","author":"Y Shi","year":"2022","unstructured":"Shi Y, Ge C, Fang D, Wei W, Li L, Wei Q, Yu H (2022) NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial\u2013mesenchymal transition by activating the Wnt\/\u03b2-catenin signaling pathway. Cancer Cell Int 22:119","journal-title":"Cancer Cell Int"},{"key":"4344_CR81","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.3390\/ijms23126702","volume":"23","author":"DC Stieg","year":"2022","unstructured":"Stieg DC, Wang Y, Liu L-Z, Jiang B-H (2022) ROS and miRNA dysregulation in ovarian cancer development, angiogenesis and therapeutic resistance. Int J Mol Sci 23:6702","journal-title":"Int J Mol Sci"},{"key":"4344_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107483","volume":"149","author":"HO Tawfik","year":"2024","unstructured":"Tawfik HO, Mousa MH, Zaky MY, El-Dessouki AM, Sharaky M, Abdullah O, El-Hamamsy MH, Al-Karmalawy AA (2024) Rationale design of novel substituted 1, 3, 5-triazine candidates as dual IDH1 (R132H)\/IDH2 (R140Q) inhibitors with high selectivity against acute myeloid leukemia: in vitro and in vivo preclinical investigations. Bioorg Chem 149:107483","journal-title":"Bioorg Chem"},{"key":"4344_CR83","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3389\/fphar.2020.01289","volume":"11","author":"W Tian","year":"2020","unstructured":"Tian W, Jiang X, Kim D, Guan T, Nicolls MR, Rockson SG (2020) Leukotrienes in tumor-associated inflammation. Front Pharmacol 11:1289","journal-title":"Front Pharmacol"},{"key":"4344_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.placenta.2023.07.002","volume":"139","author":"D Tiwari","year":"2023","unstructured":"Tiwari D, Choudhury SS, Nath T, Bose S (2023) An investigation into the role of Notch signaling, altered angiogenesis, and inflammatory-induced preterm delivery and related complications in Northeast Indian patients. Placenta 139:172\u2013180","journal-title":"Placenta"},{"key":"4344_CR85","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.2147\/CMAR.S215729","volume":"11","author":"P Ubezio","year":"2019","unstructured":"Ubezio P (2019) Beyond the T\/C ratio: Old and new anticancer activity scores in vivo. Cancer Manag Res 11:8529\u20138538","journal-title":"Cancer Manag Res"},{"key":"4344_CR86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11033-023-09032-w","volume":"51","author":"V Vahitha","year":"2024","unstructured":"Vahitha V, Lali G, Prasad S, Karuppiah P, Karunakaran G, AlSalhi MS (2024) Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions. Mol Biol Rep 51:61","journal-title":"Mol Biol Rep"},{"key":"4344_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.956793","volume":"12","author":"M Wang","year":"2022","unstructured":"Wang M, Liu X, Chen T, Cheng X, Xiao H, Meng X, Jiang Y (2022) Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways. Front Oncol 12:956793","journal-title":"Front Oncol"},{"key":"4344_CR88","doi-asserted-by":"publisher","first-page":"148711","DOI":"10.1016\/j.brainres.2023.148711","volume":"1825","author":"X Wang","year":"2024","unstructured":"Wang X, Gan W, Kang M, Lv C, Zhao Z, Wu Y, Zhang X, Wang R (2024) Asthma aggravates alzheimer\u2019s disease by up-regulating NF-\u03baB signaling pathway through LTD4. Brain Res 1825:148711","journal-title":"Brain Res"},{"key":"4344_CR89","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12890-024-03273-6","volume":"24","author":"T Xue","year":"2024","unstructured":"Xue T, Zhang Q, Zhang T, Meng L, Liu J, Chai D, Liu Y, Yang Z, Jiao R, Cui Y (2024) Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice. BMC Pulmonary Medicine 24:456","journal-title":"BMC Pulmonary Medicine"},{"key":"4344_CR90","doi-asserted-by":"publisher","first-page":"108455","DOI":"10.1016\/j.pharmthera.2023.108455","volume":"248","author":"H Yang","year":"2023","unstructured":"Yang H, Rothenberger E, Zhao T, Fan W, Kelly A, Attaya A, Fan D, Panigrahy D, Deng J (2023) Regulation of inflammation in cancer by dietary eicosanoids. Pharmacol Ther 248:108455","journal-title":"Pharmacol Ther"},{"key":"4344_CR91","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3892\/etm.2022.11370","volume":"24","author":"S Yu","year":"2022","unstructured":"Yu S, Chen X, Li X, Yan J, Jiang Y (2022) Neuroprotective effects of CysLTR antagonist on Streptococcus pneumoniae-induced meningitis in rats. Exp Ther Med 24:443","journal-title":"Exp Ther Med"},{"key":"4344_CR92","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/cancers13040717","volume":"13","author":"E Zacksenhaus","year":"2021","unstructured":"Zacksenhaus E, Egan SE (2021) Progression to metastasis of solid cancer. Cancers 13:717","journal-title":"Cancers"},{"key":"4344_CR93","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6:263","journal-title":"Signal Transduct Target Ther"},{"key":"4344_CR94","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.3390\/cancers13205106","volume":"13","author":"N Zhdanovskaya","year":"2021","unstructured":"Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R (2021) Targeting notch to maximize chemotherapeutic benefits: rationale, advanced strategies, and future perspectives. Cancers 13:5106","journal-title":"Cancers"},{"key":"4344_CR95","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopha.2018.12.064","volume":"111","author":"X Zhou","year":"2019","unstructured":"Zhou X, Cai J, Liu W, Wu X, Gao C (2019) Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-\u03b1-induced endothelial inflammation. Biomed Pharmacother 111:452\u2013459","journal-title":"Biomed Pharmacother"},{"key":"4344_CR96","first-page":"301","volume":"11","author":"W Zhou","year":"2021","unstructured":"Zhou W, Yang L, Nie L, Lin H (2021) Unraveling the molecular mechanisms between inflammation and tumor angiogenesis. Am J Cancer Res 11:301","journal-title":"Am J Cancer Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04344-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:01:50Z","timestamp":1764824510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4344"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04344-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol for the animal study received approval from the Research Ethics Committee at the Faculty of Pharmacy, Ahram Canadian University, Egypt (Ethics code:\n                      REC3024\n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This is not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}